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Abstract
Snake venom galactoside-binding lectins (SVgalLs) comprise a class of toxins capable of recognizing and interacting with
terminal galactoside residues of glycans. In the past 35 years, since the first report on the purification of thrombolectin
from Bothrops atrox snake venom, several SVgalLs from Viperidae and Elapidae snake families have been described, as has
progressive improvement in the investigation of structural/functional aspects of these lectins. Moreover, the advances of
techniques applied in protein-carbohydrate recognition have provided important approaches in order to screen for
possible biological targets. The present review describes the efforts over the past 35 years to elucidate SVgalLs,
highlighting their structure and carbohydrate recognition function involved in envenomation pathophysiology and
potential biomedical applications.
Keywords: Snake venom, C-type lectin, Galactoside-binding protein, Carbohydrate recognition domain, Glycoconjugates,
Inflammatory response, Antitumor activity, Bactericidal activity, Mitogenic activity, Platelet aggregation
Introduction
Lectins are non-enzyme and non-immune proteins cap-
able of binding reversibly, specifically and non-
covalently to carbohydrates, and have been isolated from
plants, microorganisms and animal sources [1]. Al-
though distinct lectins lack primary structural similarity,
they share similar glycan-binding specificities in which
the carbohydrate recognition domain (CRD—repre-
sented by a segment of limited amino acid residues
within the lectin) is responsible for the glycan-
interaction activity [2, 3].
Among animal sources, calcium dependent (C-type)
lectins have been identified in snake venoms and are
classified into two distinct groups: the true C-type
glycan-binding lectins; and C-type lectin-like proteins.
The C-type lectin-like (also named “snaclecs” from snake
venom C-type lectins [4]) are heterodimeric proteins
with CRD-related lectin-like domain that are not capable
of interacting specifically with sugars [5]. On the other
hand, the glycan-binding C-type lectins are homodimeric
proteins, composed of two identical disulfide-linked
polypeptide monomers with molecular mass of
approximately 15 kDa, presenting a functional CRD that
binds to carbohydrates and are capable of inducing
hemagglutination by recognizing erythrocyte surface gly-
coconjugates [6].
The first studies on snake venom lectins were reported
by Flexner and Noguchi [7] wherein the authors ob-
served agglutination activity of erythrocytes and leuko-
cytes by a variety of venoms. However, the first data on
the isolation of a snake venom lectin was reported by
Gartner et al. [8] almost 80 years later, describing the
purification and characterization of thrombolectin, the
first galactoside-binding lectin isolated from Bothrops
atrox. Since then, several reports on purification and
both the structural and functional characterization of
snake venom lectins have been described from the snake
families Viperidae and Elapidae, including from the gen-
era Bothrops, Crotalus, Bitis, Agkistrodon, Lachesis, Den-
droaspis and Trimeresurus. Most snake venom glycan-
binding lectins are members of the C-type galactoside-
binding proteins due to their ability to interact with ter-
minal galactoside residues in a calcium-dependent man-
ner [8–21]. The lectin isolated from Lachesis muta
stenophrys (LmL) was first classified as lectin-like by the
authors [10]. However, taking into account its molecular
and functional aspects (which will be further discussed
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in this review), a more appropriate definition was pro-
vided by classifying it as a true galactose-binding lectin.
The present review aims to introduce the efforts over
the past 35 years on the study of snake venom
galactoside-binding C-type lectins (SVgalLs) by provid-
ing insights on the structural and biological activities as-
sociated with its glycan recognition pattern.
Review
Molecular structure analysis
Important advances in molecular analysis and structure
determination of SVgalLs have been performed during
the past years. Although the detail of structural informa-
tion on these lectins varies from a single SDS-PAGE mo-
lecular mass analysis to a complete quaternary structure
determination, overall molecular aspects indicate a high
similarity among these proteins as will be discussed in
this section. Currently, rattlesnake lectin (RSL), from
Crotalus atrox venom, is the only SVgalL whose
complete structure was determined by X-ray crystallog-
raphy [22], and is widely applied in structural analysis
comparisons with others lectins from this class [6].
All SVgalLs are homodimeric proteins composed of
disulfide-linked monomers presenting molecular mass
varying from 14 to 16.2 kDa. The primary structures of
12 SVgalLs were determined, and presented from 134 to
136 amino acid residues as described for the following
lectins: RSL—rattlesnake lectin from Crotalus atrox [23],
ApL—Agkistrodon piscivorus piscivorus lectin [15],
BaL—Bitis arietans lectin [13], CrL—Crotalus ruber lec-
tin [18], BiL—Bothrops insularis lectin [16], BmLec—Bo-
throps moojeni lectin [24], BpalL—Bothrops pauloensis
lectin [21], BJcuL—Bothrops jararacussu lectin [25],
BpirL—Bothrops pirajai lectin [17], LmL—Lachesis muta
stenophrys lectin [26], ToL—Trimeresurus okinavensis
lectin [27] and TsL—Trimeresurus stejnegeri lectin [28].
Amino acid sequence analysis among the referenced
SVgalLs using BLAST searching tool [29] showed an
identity degree from 82 to 97 % among them, indicating
a high primary structural similarity within these lectins.
A multiple alignment comparing RSL primary and sec-
ondary structures with the mentioned lectins was per-
formed. As shown in Fig. 1, sequence identities vary
from 83 to 94 % when compared to RSL, presenting im-
portant conserved structural features such as positioning
Fig. 1 Multiple alignment of SVgalL. The multiple alignment was performed using the program Clustal-X, and sequence similarities using ESPript
3.0 [73] with structure prediction based on RSL structure [PDB: 1JZN]. Fully conserved residues are highlighted in red background. Cystein residues
involved in the interchain disulfide link are indicated by green numbers. Carbohydrate recognition domain (CRD) is indicated by the blue box.
Primary structure according to lectins: RSL [GI: 126130], ApL [GI: 510120659], BaL [GI: 34922645], CrL [GI: 118572769], BiL [GI: 82126834], BmLec
[24], BpalL [GI: 527504051], BJcuL [25], BpirL [GI: 510120660], LmL [GI: 1881829], ToL [27] and TsL [GI: 7674107]
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of cysteine residues. The eight to nine highly conserved
cysteine residues within these SVgalLs indicate the pres-
ence of four intramolecular Cys-Cys disulfide-linkages
(Cys3–Cys14, Cys31–Cys131, Cys38–Cys133 and Cys106–
Cys123), as determined for the RSL structure (Fig. 1).
Furthermore, Cys86 is directly involved in the interchain
disulfide link in order to compose the dimeric structural
pattern of RSL [22], as observed with the same position-
ing residue for the other SVgalLs (Fig. 1).
Secondary structural content analysis by circular di-
chroism was assessed for certain SVgalLs. The Bothrops
leucurus Lectin (BleucL) and LmL contained mainly β
structures (68 and 78 % respectively) with only 1 % α
structures, thus being classified as a β class protein,
while BJcuL possesses 18.8 % α-helix and 32.2 % β-sheet,
and is classified as a α + β class protein [20, 30]. Walker
et al. [22] determined that RSL structure is comprised of
eight β-sheets and two α-helixes (Fig. 2a). As observed
in Fig. 1, RSL amino acid residues involved in secondary
structure are composed of highly conserved residues
within other SVgalLs. This secondary structure
conformation is supported by intermolecular interac-
tions involving intra-monomeric amino acid segments.
Residues H99 and F105 in conjunction with D72 from
RSL, and conserved in the other lectins, appear to be in-
volved in the stabilization of the loop between β-sheet 4
and β5, the CRD site, and β7 (Fig. 1) [22]. As to the di-
meric form, in addition to cystine interaction of inter-
monomeric, electrostatic interactions between RSL
monomers interface are maintained by salt bridges and
hydrogen bonds [22].
In general, C-type galactoside-binding lectins CRD
motifs are represented by three amino acid residues,
Gln-Pro-Asp, which are considered to be determinants
of their galactose specificities, where this carbohydrate
interaction is mediated by calcium ions [31]. As shown
in Fig. 1, this motif is fully conserved within all SVgalLs
with primary structure determined, indicating its com-
mon carbohydrate recognition activity. As observed in
the RSL structure complexed with lactose in Fig. 2b, the
CRD is responsible for coordinating the calcium ion by
interacting with the residues Q96, D98, E104, N119 and
Fig. 2 RSL tertiary structure and carbohydrate binding site. RSL structure as described elsewhere [22]. a A cartoon representation of the RSL dimer
complexed with lactose. Cysteine side and inter chains are shown in yellow, calcium and sodium ions are represented as red and orange circles,
respectively, and lactose is shown in stick representation colored in red. b Cartoon representation of the carbohydrate-binding site interacting with
lactose. c Oligomerization state with the decamer viewed down the pseudo-5-fold rotation axis. The 3D structure illustration was performed using the
software Pymol (The PyMOL Molecular Graphics System, Version 1.5.0.4 Schrödinger, LLC.) from RSL entry [PDB: 1jzn]
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D120. The interaction with galactose residue from lactose
(a disaccharide composed of galatose-glucose) occurs by
coordination of galactose hydroxyl groups at position 3
and 4 of the hexose ring with the calcium ion (Fig. 2b)
and by direct hydrogen bonds to residues Q96, D98, E104
and N119. Furthermore, the residue Q121 is involved in
water-mediated hydrogen bond coordination of the 2-
hydroxyl group of the galactose moiety, while residue
Y100 also interacts with the galactose ring [22].
The aspects involving the galactose binding specificity
of lectins are related to the hydrogen-bond interaction
of residues Q96 and D98 with the galactose 3 and 4-
hydroxyl groups, as observed in RSL [22], differently
from mannose binding protein in which CRD is com-
posed of an EPN motif (glutamic acid, proline and as-
paragine), whereas interaction with mannose 3-OH
involves coordination of the calcium ion and simultan-
eous hydrogen bonding to residues E and N [32]. Aside
from its CRD responsible for galactose binding activity
mediated by calcium ion, RSL shows an alternative ion
binding site that coordinates a sodium ion by residues
Y15, S42, and Q132 and a water molecule, (Fig. 2a) [22].
This ion binding site is thought to be important in sta-
bilizing RSL conformation [22], where the presence of
these amino acids is fully conserved in the other SVgalLs
and might also have an effect on these lectins (Fig. 1).
It has been reported that SVgalLs are capable of form-
ing high-order oligomers [22, 33]. The X-ray crystallog-
raphy structure of RSL reveals a decameric protein
composed of five disulfide-linked dimers (ten monomers
in total) arranged as two pseudo-5-fold symmetric pen-
tamers as shown in Fig. 2c. As in the case of RSL, evalu-
ation of BJcuL quaternary structure using different
computational methods and biophysical experiments
such as small-angle X-ray light scattering, revealed that
the lectin, in solution, is a globular protein with molecu-
lar mass of 147.5 kDa with indications that BJcuL also
forms an oligomerized decameric structure [33].
The decameric complex of RSL is composed of five di-
mers (Cys86–Cys86 disulfide-linked monomers) arranged
as two pentamers (Fig. 2c), where its oligomeric struc-
ture is mainly maintained by four salt bridges and apolar
interactions [22]. The fact that the RSL decameric struc-
ture presents ten carbohydrate-binding sites located on
the edge of the two pentamers strongly suggests that the
lectin presents a multivalent capacity of ligand-binding
activity, as shown by its ability to induce erythrocyte ag-
glutination due to cross-linking with the opposing cell
surface. The ability to mediate multivalent interactions
with different biological glycoconjugates have been de-
scribed for others SVgalLs, such as galatrox, from
Bothrops atrox snake venom, which induces a pro-
inflammatory activity through its interaction with
galactose-bearing glycoconjugates on the surface of
neutrophils and macrophages and extracellular matrix
(ECM) proteins [34].
Glycan specificity
Given the effect of lectins on biological functions,
understanding the molecular basis of carbohydrate
recognition pattern comprises a relevant issue in lec-
tinomics [35, 36]. So far, with the exception of the
mannose-binding lectin isolated from Oxyuranus scu-
tellatus crude venom [37], most snake venom
glycan-binding lectins present the ability to interact
specifically with sugars via terminal galactoside resi-
dues [6]. Interestingly, this similarity of galactose
recognition patterns is reflected in several aspects
among SVgalLs, such as the purification procedure
which, for most snake lectins, is performed by single
step liquid chromatography using affinity resins with
a matrix composed of lactose- or galactose-based
components [8–21, 38–41].
The major reported efforts to evaluate the carbohy-
drate binding specificity of SVgalLs consisted of asses-
sing the capacity of sugars to inhibit erythrocyte
agglutination activity. The results obtained for each
SVgalLs assessed shows that glycans with terminal galac-
toside residue presented the most inhibitory efficiency.
Although a similar galactose recognition pattern among
these lectins, possibly associated with the structural as-
pects related to the CRD motif, variations in galactoside
residues such as substitution of secondary disaccharide
linkage or introduction of substituent e.g. methyl or
amine groups on terminal galactoside residue intensifies
or decreases lectin recognition specificity (Table 1).
Lately, the advances in protein-carbohydrate recogni-
tion methods have included the introduction of new
techniques, thus opening doors to the improvement of
protein-sugar specificity using a variety of glycans that
mimic biological sources of glycoconjugates [36]. More
refined data on the investigation of carbohydrate-SVgalL
interaction were obtained for RSL [42] and Galatrox [34]
by performing the glycan microarray at the Consortium
for Functional Glycomics (Protein-Glycan Interaction
Core). The technique comprises a solid phase system
screening to evaluate the recognition of proteins (such as
lectins) in a wide range of immobilized glycans structures
[43]. Both SVgalLs assessed presented a similar pattern of
carbohydrate recognition to N-acetyllactosamine glycans,
composed of terminal galactose (Gal) residue bonded to
N-acetyl-glucosamine (GlcNAc) at the non-reducing end
of the glycans (Fig. 3a and b). This finding is consistent
with the results on hemagglutination inhibition (Table 1).
Young et al. [42] observed that among over 264 glycan
structures, RSL presented binding affinity preferentially to
glycans with terminal Gal(α or β) or GalNAc(α) residues
bonded to GlcNAc (Fig. 3a). As for galatrox [34], the
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lectin presented a significant specific preference for ter-
minal Gal(β) bonded to GlcNAc glycans among over 406
structures analyzed (Fig. 3b). Additionally, the modifica-
tion of terminal lactosamine structures, such as insertion
of fucose or sialic acid on terminal Gal residues or substitu-
tion of the secondary monosaccharide from GlcNAc, dis-
favors the recognition intensity of both SVgalLs [34, 42].
These results have been highly constructive for elucidating
the carbohydrate recognition pattern of these SVgalLs to
different biological glycans, and have facilitated the eluci-
dation of molecular mechanisms of these lectins in the
biological events later described in this work.
Biological functions
Glycans are found in living systems as free oligosaccha-
rides or as glycoconjugates present on the cell surface and
ECM, and are involved in a broad spectrum of biological
functions including the signaling, recognition and adhe-
sion of molecules [1, 36, 44]. The recognition of specific
glycans by lectins represents a key event in a variety of
biological phenomena involving cell-cell and cell-ECM
component interactions, as observed in cell migration,
apoptosis, immunomodulation and inflammation, host
pathogen interactions and mitogenic induction [1, 45].
The SVgalLs comprise a group of exogenous glycan
binding proteins (GBP) that have been reported to medi-
ate several biological functions associated with snake en-
venomation pathophysiology and other biological
properties [8, 11, 13, 34, 46–49]. The present section will
approach functional features of SVgalLs and the associ-
ation of their carbohydrate recognition specificity in
these activities.
Mitogenic activity
In addition to hemagglutination activity, the ability of lec-
tins to stimulate lymphocytes to undergo mitosis has been
described from the early 1960s [50]. Since then, several
other lectins from different sources have been reported to
induce cell mitogenisis through recognition of sugars on
the cell surface leading to signal transmission [3].
Subsequent to the early reports on biological
characterization of SVgalLs, authors have assessed
their ability to induce mitogenic activity. Mastro et al.
[46], in a study working with five different SVgalLs,
have shown that RSL, cottonmouth lectin (CML—
isolated from Akgistrodon piscivorus leukostoma
venom) and Dendroaspis jamesonii lectin (Jameson’s
Table 1 Carbohydrate inhibition specificity of SVgalLs
SVgalL Snake species Terminal galactoside carbohydrates (inhibition order)
ApL Akgistrodon piscivorus
piscivorus [15]
D-galactose > Lactose > N-acetyl-D-galactosamine
Thrombolectin Bothrops atrox [9] Thiodigalactoside > Lactose > Methyl β-D-galactopyranoside >Methyl α-D-galactopyranoside > D-
galactose
BiL Bothrops insularis [16] Thiodigalactoside > Lactose > D-galactose > N-acetyl-D-galactosamine
BjL Bothrops jararaca [12] Thiodigalactoside > Lactose = N-acetyl-lactosamine >Methyl β-D-galactoside = D-galactose > Methyl α-D-
galactoside > N-acetyl-D-galactosamine
CML Akgistrodon piscivorus
leukostoma [9]
Thiodigalactoside > Lactose > Methyl β-D-galactopyranoside > D-galactose >
Methyl α-D-galactopyranoside
BJcuL Bothrops jararacussu [14] Lactose > D-galactose > D-galactosamine
RSL Crotalus atrox [9] Thiodigalactoside > Lactose > Methyl β-D-galactopyranoside = D-galactose >
Methyl α-D-galactopyranoside
BleucL Bothrops leucurus [20] D-galactose > Lactose > N-acetyl-D-glucosamine > asialofetuin
BpaL Bothrops pauloensis [21] Lactose > D-galactose > N-acetyl-D-galactosamine
BpL Bothrops pirajai [17] Lactose > D-galactose
CuHL Akgistrodon contortrix
contortrix [9]
Thiodigalactoside > Methyl β-D-galactopyranoside > Lactose > Methyl α-D-galactopyranoside > D-
galactose
CrL Crotalus ruber [18] Thiodigalactoside > N-acetyl-D-galactosamine = Lactulose > Lactose =
Methyl β-D-galactoside > D-galactose
LmL Lachesis muta stenophyrs
[10]
Thiodigalactoside > Lactose > Methyl β D-galactopyranoside > D-galactose >
Methyl α D-galactopyranoside > Galactosamine
ToL Trimeresurus okinavensis
[27]
Thiodigalactoside = Lactose
JML Dendroaspis jamesonii [10] Thiodigalactoside = Lactose > Methyl α D-galactoside >Metyl β D-galactoside > D-galactose >
Galactosamine
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mamba lectin—JML) were capable of stimulating
lymphocytes to undergo DNA synthesis, unlike
thrombolectin and copperhead lectin (CuHL—isolated
from Akgistrodon contortrix contortrix venom). The
authors also showed that lymphocyte mitogenic
activity of CML was preferentially induced in T-cells
rather than B-cells, and was mediated by its carbohy-
drate binding properties. Moreover, CML macro-
phages stimulation increased lymphocyte proliferation
presumably by involving interleukin-1 production
from macrophages [46].
Other SVgalLs have also been assessed for their mito-
genic activity, in which ToL was described as inducing the
proliferation of human peripheral lymphocytes, mouse
macrophages and bovine arterial endothelial cells [27].
On the other hand, Bothrops godmani Lectin (BgL)
induced no mitogenic activity in human peripheral
blood mononuclear cells [11]. The variation observed
in the mitogenic activity among SVgalLs may be asso-
ciated with the carbohydrate-binding specificity of
these lectins, associated with a glycosylation pattern
of cell surface receptors that are involved in this
phenomenon [46].
Platelet aggregation
Investigations into the involvement of SVgalLs in the
hemostasis system evidenced that these lectins act exclu-
sively on platelet functions, as shown by the platelet ag-
gregation agonists BmLec [24], RSL [51], Agkistrodon
piscivorus leukostoma lectin (AplLec [51]), ToL [27] and
LmL [51]. The proposed mechanism of platelet activa-
tion was based on the report of Ogilvie et al. [51], which
showed that LmL recognizes glycans on the platelet sur-
face and induces platelet aggregation mediated by glyco-
protein IIb/IIIa signaling. Therefore, considering the
binding specificity of SVgalLs, these results also indicate
the presence of terminal galactoside residues on platelet
surface glycoconjugates, where the recognition by the
lectins seems to initiate the platelet stimulation and pos-
sibly induce blood coagulation disorders associated with
snakebites.
Fig. 3 Glycan-recognition specificity. Top five glycan structures with highest binding recognition by the SVgalLs (a) RSL and (b) galatrox assessed
by glycan microarray as described elsewhere [34, 42]
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On the other hand, several other lectins were not cap-
able of inducing or inhibiting platelet aggregation,
namely CuHL [51], galatrox [19], BjL [12], BJcuL [41],
thrombolectin [51] and CrL [18]. This functional diver-
sity involving platelet function may be associated with
differences in the carbohydrate recognition specificity
among SVgalLs [51].
Inflammation
Several endogenous and exogenous GBPs have been de-
scribed as playing a pivotal role by regulating the partici-
pation of a wide variety of events during inflammation
[52–56]. The participation of SVgalLs in inflammatory
response has been assessed using different animal
models and in vitro approaches in order to evaluate
leukocyte involvement and recognition of ECM glyco-
conjugates in the inflammatory response.
Lomonte et al. [11] evidenced that BgL was capable of
inducing moderate acute phase mouse paw edema that
was inhibited by the antihistamine drug cyproheptadine.
A similar pattern of acute mouse paw edema was ob-
served in BJcuL, an effect that was associated with an in-
crease in local vascular permeability [41]. Considering
that galatrox and LmL were not capable of inducing
mouse paw edema [19, 30, 57], the above results indicate
that SVgalLs-induced paw edema might be associated
with the capacity of the lectins to stimulate resident
mast cell degranulation and the release of histamine
and/or serotonin in order to trigger local inflammatory
response.
In addition to paw edema, investigations concerning
different sites of SVgalLs-induced inflammation and the
involvement of leukocytes and ECM glycoproteins have
been assessed. Elifio-Esposito et al. [58] demonstrated
that BJcuL induced an increase in rolling and adherence
of leukocytes observed in cremaster muscle microvessels
of mice with topical administration of the lectin. Add-
itionally, the authors also demonstrated that the lectin is
capable of binding to the glycoproteins’ fibronectin and
vitronectin, assuming that the extravasation of periph-
eral blood leukocytes into the inflammatory site involves
cellular adhesion to ECM proteins mediated by BJcuL
[58]. In order to confirm this evidence and elucidate the
involvement of neutrophils in BJcuL-induced inflamma-
tion, a continuous study by Elifio-Esposito et al. [49] was
performed by applying in vitro approaches. The authors
observed that BJcuL not only recognizes glycoligands
on the neutrophil cell surface, but also promotes
polarization and migration, and enhances adhesion to the
ECM components fibronectin and matrigel. The lectin
also induced neutrophil functional activation by increasing
phagocytosis and superoxide production [49].
Similar findings were also reported by Sartim et al.
[34], who evaluated the pro-inflammatory response of
galatrox. Although the lectin was not capable of indu-
cing paw edema [19], in mice it was capable of promot-
ing acute neutrophil migration into the peritoneal cavity
and the release of cytokines IL-1α and IL-6. Moreover,
galatrox was capable of recognizing neutrophil cell
membrane glycoconjugates, of interacting with the poly-
lactosamine ECM component laminin, and also inducing
neutrophil chemotaxis in vitro [34]. Interestingly, the
possible involvement of resident cells on galatrox-
induced inflammation was assumed due to the ability of
the lectin to stimulate macrophages in vitro to produce
the pro-inflammatory mediators IL-6 and TNF-α, and
keratinocyte-derived chemokine by interacting and trig-
gering toll-like receptor 4 signaling in an MyD88-
dependent pathway [34].
The above results show that the inflammatory-induced
mechanism of the mentioned SVgalLs is characterized
by neutrophil influx to the inflammation site promoted
by direct lectin-ECM interaction chemoattractive role
and/or through stimulation of resident macrophages or
mast cells in order to express soluble mediators respon-
sible for amplifying the inflammatory response. An ex-
ceeding inflammatory process induced by these lectins,
and others venom components, may be associated with
snake envenomation pathophysiology related to tissue
damage and organ injury [59, 60].
Renal effects
During snake envenomation, renal disorders represents
an important clinical manifestation where the kidney
represents an organ vulnerable to venom components
due to its high degree of vascularization. Multiple factors
including hemodynamic changes, inflammatory reactions
and nephrotoxic effects of toxins are responsible for sev-
eral manifestations such as proteinuria, hematuria and
renal failure [61]. Studies involving the evaluation of
renal disorders induced by SVgalLs in isolated rat kid-
neys have been reported. The lectins BiL, BpirL and
BmLec were capable of inducing alterations in renal
functional parameters such as perfusion pressure, renal
vascular resistance, urinary flow, glomerular filtration
rate and tubular ion transport [17, 24, 48]. Moreover,
indomethacin, an anti-inflammatory drug that inhibits li-
pidic mediator prostaglandin synthesis, completely
inhibited all evaluated parameters of renal alterations in-
duced by BmLec [24]. Additionally, histological analysis
of kidneys from animals that received BiL suggested dir-
ect injury to glomerular and tubular renal cells [48].
Therefore, a rational proposal on the mechanism of renal
alterations suggested by the authors indicates a direct
cytotoxicity induced by the lectins at the glomerular level
and/or the involvement of systemic pro-inflammatory
mediators such as prostaglandins, suggesting their
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involvement in envenomation-induced renal disorders
[17, 24, 48].
Other biological functions
As mentioned above, SVgalLs are able to recognize and
interact with several biological glycoconjugates in order
to induce their functional activity, being associated with
snakebite-related pathologies. However, given the ad-
vance of emerging techniques applied to determine the
carbohydrate composition of glycoconjugates in associ-
ation with the large amount of data on lectin-glycan rec-
ognition, the investigation of novel applications of these
snake venom GBPs has been largely completed [1, 36, 43].
Ryanodine receptors are calcium-release channels
expressed in several human cells such as those present
in sarcoplasmatic reticulum (SR) from skeletal muscle,
and are associated with muscle contraction [62]. A wide
variety of compounds from diverse natural sources have
been assessed as molecular approaches to elucidate the
molecular mechanism of calcium-release involving rya-
nodine receptors. Among these chemical probes, the
snake venom lectins ToL and BaL were reported to trig-
ger calcium release specifically from a heavy fraction of
skeletal muscle SR (HSR) by interacting with HSR rya-
nodine receptors, where the binding sites by which both
SVgalLs interact appeared to be different from those
sites able to recognize the well known agonists caffeine,
ryanodine and myotoxin alpha, isolated from Crotalus
viridis viridis venom [39, 47]. These findings indicate
both lectins as possible novel pharmacological tools for
application in functional studies of calcium release from
HSR in skeletal muscle.
Considering that during the infection process patho-
gen adhesion to the host cell involves protein-glycan in-
teractions [63, 64], glycoconjugates from the pathogen
cell surface represents a potential target for SVgalLs.
Castanheira et al. [21] showed that BpalL, a lectin iso-
lated from Bothrops pauloensis venom, induced agglutin-
ation but not toxicity of promastigote forms of
Leishmania amazonesis through interaction with galac-
toside glycoconjugates on the parasite membrane. The
effects of BpalL on bacteria were also evaluated, where
the lectin inhibited gram-positive Staphylococcus aureus
growth, but not gram-negative E.coli [21]. Similar find-
ings were also obtained for BleucL, isolated from
Bothrops leucurus venom, which promoted antibacterial
activity against gram-positive bacteria Bacillus subtilis,
Staphylococcus aureus and Enterococcus faecalis, but not
against gram-negative E. coli or Klebsiella pneumonia
[20]. The authors suggested that the difference in sus-
ceptibility is associated with the interaction of BpalL and
BleucL with peptidoglycan present in the gram-positive
bacterium cell wall, while the lectins may not reach the
same targets on Gram-negative due to the outer cell wall
[20, 21]. In contrast, BmLec, isolated form Bothrops
moojeni venom, induced bactericidal activity against
gram-negative Xanthomonas axonopodis pv. passiflorae,
where ultrastructural analysis showed that the lectin
binds to the membrane resulting in the formation of the
bacterial aggregates, and also the development of large
vesicles in the bacterial cell membrane that lead to
membrane rupture [24]. This contrast in relation to the
effects to gram-negative bacteria among the mentioned
SVgalLs may be associated with the variation of carbohy-
drate binding specificity of these lectins to outer cell wall
glycoconjugates or even to morphological singularities
among bacteria [65].
Genetic alterations in malignant tumor cells are asso-
ciated with changes in their glycosylation patterns when
compared to normal cells, which include an increased
expression of unusual terminal carbohydrate sequences
[66, 67]. Considering that this novel pattern of surface
glycoconjugates might develop malignant cells into novel
targets for lectins, a progressive number of investigations
on the involvement of SVgalLs in cancer cells have been
launched. The evaluation of SVgalLs-induced cytotox-
icity in vitro became the most common effort reported
where, as shown in Table 2, the lectins assessed were
capable of inducing toxicity against a wide variety of
tumor cell lines through recognition of membrane glyco-
conjugates. Most cell death was reported to be induced
by apoptotic signals as shown for BJcuL against the
MKN45, AGS and HT29 cell lines [68, 69], and BleucL
against the K562 cell line [70]. Interestingly, apoptosis
represents an essential mechanism by which several che-
motherapeutic agents act [71], indicating a potential ap-
plicability of these lectins. As to intracellular signaling
mechanisms of cell death, Damasio et al. [69] observed
that BJcuL triggers a cascade of kinases via the activation
of tumor necrosis factor-related apoptosis-inducing
Table 2 SVgalL tumoral cell lines citotoxicity
SVgalL Snake venom specie
(reference)
Tumorigenic cell line
Galatrox Bothrops atrox [19] HL-60 (human promyelocytic leukemia)
BJcuL Bothrops jararacussu
[68, 69, 74]
MDA-MB- 435 (human breast carcinoma); OVCAR-5 (ovarian carcinoma); U87 and A-172 (glioblastoma); MKN45
and AGS (human gastric carcinoma); HT29 (human colon adenocarcinoma)
BleucL Bothrops leucurus
[70, 72]
K562 (human chronic myelocytic leukemia); NCI-H292 (human lung mucoepidermoid carcinoma); Hep-2 (human
larynx epidermoid carcinoma); B16-F10 (melanoma)
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ligand receptors on HT29 cell line, involving expression
of Fas-associated death domain, caspase-8 and Bax pro-
teins, and leading to cell apoptosis.
Moreover, the authors also observed that the lectin in-
creases the permeability of the external mitochondrial
membrane and induces respiration decrease [69]. Similar
findings on mitochondrial dysfunction were also ob-
served for BleucL toxicity toward the B16-F10 cell line,
which induced the increase of calcium concentrations in
cytosol and mitochondrial superoxide generation, and
favored mitochondrial permeability transition pore
opening, leading to cell death by necrosis [72]. Des-
pite its cytotoxicity toward tumor cell lines, BleucL
presented no changes in viability of the nontumori-
genic HaCaT cells derived from human keratinocytes,
indicating a selective death-induced activity towards
cancer cells [70, 72]. Aside from cytotoxicity, SVgalLs
presented other features involving antitumor activity
as evidenced by BJcuL which was capable of inhibit-
ing adhesion of HT29, MKN45 and AGS cell lines to
ECM components within matrigel, indicating an im-
portant mechanism to annul the attachment of cancer
cells to tissue [68, 69]. The abovementioned findings
suggest these lectins as potential anticancer agents
owing to their abilities to recognize, kill and suppress
common features of tumor cell lines during cancer
progression.
Conclusion
During the past 35 years, scientists have shown that snake
venoms represent an important source of galactoside-
binding lectins that are involved in diverse features of
snake biology. The specificity towards terminal galactose
residues confers to these molecules the ability to recognize
a wide variety of glycoconjugates, and act as an important
tool in glycan-codified functions. This capacity corrobo-
rates these lectins as potential approaches applied in basic
research, clinical diagnosis and pharmacological therapy.
Therefore, future studies on SVgalLs become crucial not
only for the elucidation of their involvement in snake en-
venomation pathophysiology, but also for the develop-
ment of biotechnological tools.
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